There appears to be considerable interest regarding CRE’s background, please see http://www.thecre.com/tpsac/?p=1132
Given the very large public response to this post, CRE will analyze the comments and prepare a White Paper for transmittal to the FDA.
TPSAC and CTR have a lot on their agenda but eventually they are going to have to develop an algorithm for addressing the “reduced harm” provisions of the new tobacco statute. In doing so they will have to be mindful of the applicability of the Data Quality Act to the resultant proceedings. Smokeless tobacco and e-cigarettes will be two issues leading the parade.